Oral glucocorticoids with intravenous cyclophosphamide or oral glucocorticoids alone in the treatment of IgA nephropathy present with nephrotic syndrome and mesangioproliferative glomerulonephritis

BACKGROUND: Few studies have evaluated the treatment of immunoglobulin A nephropathy (IgAN) patients with nephrotic syndrome (NS) and mesangioproliferative glomerulonephritis (MPGN). The aim of this study was to compare the therapeutic effects of oral glucocorticoids (GCS) combined with intravenous...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Wen, Chen, Zijin, Fang, Zhengyin, Li, Junru, Weng, Qinjie, Zheng, Qimin, Xie, Lin, Yu, Hanlan, Gu, Xiangchen, Shi, Hao, Wang, Zhaohui, Ren, Hong, Wang, Weiming, Ouyang, Yan, Xie, Jingyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689133/
https://www.ncbi.nlm.nih.gov/pubmed/38046021
http://dx.doi.org/10.1093/ckj/sfad164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689133/
https://www.ncbi.nlm.nih.gov/pubmed/38046021
http://dx.doi.org/10.1093/ckj/sfad164

Ejemplares similares